nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0551	0.291	CbGbCtD
Ranolazine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0513	0.271	CbGbCtD
Ranolazine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0235	0.124	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0231	0.122	CbGbCtD
Ranolazine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0216	0.114	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0147	0.0777	CbGbCtD
Ranolazine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000942	0.00116	CcSEcCtD
Ranolazine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000939	0.00116	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000936	0.00115	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000935	0.00115	CcSEcCtD
Ranolazine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000933	0.00115	CcSEcCtD
Ranolazine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.00115	CcSEcCtD
Ranolazine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000932	0.00115	CcSEcCtD
Ranolazine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.00114	CcSEcCtD
Ranolazine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000925	0.00114	CcSEcCtD
Ranolazine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000925	0.00114	CcSEcCtD
Ranolazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000924	0.00114	CcSEcCtD
Ranolazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000921	0.00114	CcSEcCtD
Ranolazine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000917	0.00113	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000915	0.00113	CcSEcCtD
Ranolazine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000914	0.00113	CcSEcCtD
Ranolazine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000911	0.00112	CcSEcCtD
Ranolazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000907	0.00112	CcSEcCtD
Ranolazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000906	0.00112	CcSEcCtD
Ranolazine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000904	0.00111	CcSEcCtD
Ranolazine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000896	0.00111	CcSEcCtD
Ranolazine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000891	0.0011	CcSEcCtD
Ranolazine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000891	0.0011	CcSEcCtD
Ranolazine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000889	0.0011	CcSEcCtD
Ranolazine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000889	0.0011	CcSEcCtD
Ranolazine—Rash—Topotecan—peripheral nervous system neoplasm	0.000889	0.0011	CcSEcCtD
Ranolazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000888	0.0011	CcSEcCtD
Ranolazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000888	0.0011	CcSEcCtD
Ranolazine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000886	0.00109	CcSEcCtD
Ranolazine—Cough—Etoposide—peripheral nervous system neoplasm	0.000885	0.00109	CcSEcCtD
Ranolazine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000884	0.00109	CcSEcCtD
Ranolazine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000884	0.00109	CcSEcCtD
Ranolazine—Headache—Topotecan—peripheral nervous system neoplasm	0.000883	0.00109	CcSEcCtD
Ranolazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000882	0.00109	CcSEcCtD
Ranolazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000882	0.00109	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000882	0.00109	CcSEcCtD
Ranolazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000881	0.00109	CcSEcCtD
Ranolazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000881	0.00109	CcSEcCtD
Ranolazine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00088	0.00109	CcSEcCtD
Ranolazine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000878	0.00108	CcSEcCtD
Ranolazine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000877	0.00108	CcSEcCtD
Ranolazine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000877	0.00108	CcSEcCtD
Ranolazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000876	0.00108	CcSEcCtD
Ranolazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000876	0.00108	CcSEcCtD
Ranolazine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000873	0.00108	CcSEcCtD
Ranolazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000873	0.00108	CcSEcCtD
Ranolazine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000873	0.00108	CcSEcCtD
Ranolazine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000873	0.00108	CcSEcCtD
Ranolazine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000873	0.00108	CcSEcCtD
Ranolazine—Rash—Melphalan—peripheral nervous system neoplasm	0.00087	0.00107	CcSEcCtD
Ranolazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00087	0.00107	CcSEcCtD
Ranolazine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000867	0.00107	CcSEcCtD
Ranolazine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000862	0.00106	CcSEcCtD
Ranolazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000861	0.00106	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000857	0.00106	CcSEcCtD
Ranolazine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000853	0.00105	CcSEcCtD
Ranolazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000844	0.00104	CcSEcCtD
Ranolazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000842	0.00104	CcSEcCtD
Ranolazine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000838	0.00103	CcSEcCtD
Ranolazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000837	0.00103	CcSEcCtD
Ranolazine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000835	0.00103	CcSEcCtD
Ranolazine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000834	0.00103	CcSEcCtD
Ranolazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000831	0.00102	CcSEcCtD
Ranolazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000831	0.00102	CcSEcCtD
Ranolazine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00082	0.00101	CcSEcCtD
Ranolazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00082	0.00101	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000818	0.00101	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000812	0.001	CcSEcCtD
Ranolazine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000811	0.001	CcSEcCtD
Ranolazine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00081	0.000999	CcSEcCtD
Ranolazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000996	CcSEcCtD
Ranolazine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000807	0.000996	CcSEcCtD
Ranolazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000805	0.000993	CcSEcCtD
Ranolazine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000804	0.000991	CcSEcCtD
Ranolazine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.0008	0.000987	CcSEcCtD
Ranolazine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.0008	0.000986	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000797	0.000984	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000789	0.000973	CcSEcCtD
Ranolazine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000789	0.000973	CcSEcCtD
Ranolazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000785	0.000968	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00078	0.000962	CcSEcCtD
Ranolazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000774	0.000955	CcSEcCtD
Ranolazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000773	0.000954	CcSEcCtD
Ranolazine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000763	0.000941	CcSEcCtD
Ranolazine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00076	0.000938	CcSEcCtD
Ranolazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.000925	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.000922	CcSEcCtD
Ranolazine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000744	0.000918	CcSEcCtD
Ranolazine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000743	0.000916	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.000913	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000738	0.00091	CcSEcCtD
Ranolazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000738	0.00091	CcSEcCtD
Ranolazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000735	0.000907	CcSEcCtD
Ranolazine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000733	0.000904	CcSEcCtD
Ranolazine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000727	0.000897	CcSEcCtD
Ranolazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000721	0.000889	CcSEcCtD
Ranolazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000719	0.000887	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.000884	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000882	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000714	0.000881	CcSEcCtD
Ranolazine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000713	0.00088	CcSEcCtD
Ranolazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000707	0.000873	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.00087	CcSEcCtD
Ranolazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000701	0.000865	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000693	0.000855	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000846	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000842	CcSEcCtD
Ranolazine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000682	0.000841	CcSEcCtD
Ranolazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000679	0.000838	CcSEcCtD
Ranolazine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000676	0.000835	CcSEcCtD
Ranolazine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000675	0.000833	CcSEcCtD
Ranolazine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000674	0.000831	CcSEcCtD
Ranolazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000668	0.000824	CcSEcCtD
Ranolazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000668	0.000824	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00082	CcSEcCtD
Ranolazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000664	0.000819	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000816	CcSEcCtD
Ranolazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000657	0.000811	CcSEcCtD
Ranolazine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000654	0.000807	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000649	0.000801	CcSEcCtD
Ranolazine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000649	0.000801	CcSEcCtD
Ranolazine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000648	0.000799	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000645	0.000795	CcSEcCtD
Ranolazine—Rash—Vincristine—peripheral nervous system neoplasm	0.000644	0.000794	CcSEcCtD
Ranolazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000643	0.000794	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000643	0.000793	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000791	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000641	0.000791	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00064	0.000789	CcSEcCtD
Ranolazine—Headache—Vincristine—peripheral nervous system neoplasm	0.00064	0.000789	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000783	CcSEcCtD
Ranolazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.000777	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000776	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.000758	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00061	0.000752	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000751	CcSEcCtD
Ranolazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000607	0.000748	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000747	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000741	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.000736	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.000734	CcSEcCtD
Ranolazine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000594	0.000732	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000732	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000592	0.000731	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.00073	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000588	0.000726	CcSEcCtD
Ranolazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000585	0.000722	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000719	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000718	CcSEcCtD
Ranolazine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000574	0.000708	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000705	CcSEcCtD
Ranolazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000569	0.000702	CcSEcCtD
Ranolazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000569	0.000702	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000701	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000696	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000695	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000691	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00056	0.000691	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000676	CcSEcCtD
Ranolazine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000547	0.000675	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000674	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.000671	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.000666	CcSEcCtD
Ranolazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000536	0.000662	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000661	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000653	CcSEcCtD
Ranolazine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000526	0.000649	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000649	CcSEcCtD
Ranolazine—Rash—Etoposide—peripheral nervous system neoplasm	0.000522	0.000643	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000521	0.000643	CcSEcCtD
Ranolazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000518	0.000639	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000639	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000511	0.00063	CcSEcCtD
Ranolazine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000629	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000509	0.000627	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000624	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000619	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000616	CcSEcCtD
Ranolazine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000612	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000611	CcSEcCtD
Ranolazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000491	0.000606	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000595	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000593	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000584	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000583	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000582	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000581	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000577	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000573	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.00057	CcSEcCtD
Ranolazine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000566	CcSEcCtD
Ranolazine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000563	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000561	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000454	0.00056	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000556	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000553	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.00055	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000548	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000545	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.00054	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000535	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000534	CcSEcCtD
Ranolazine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000521	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000519	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000518	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000517	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000514	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000514	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000512	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000413	0.00051	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000509	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000505	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000504	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000497	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000495	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000494	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000493	CcSEcCtD
Ranolazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000489	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000479	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000475	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000472	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000471	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000471	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000468	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000466	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.00046	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000457	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000456	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000454	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000453	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000452	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000436	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000433	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000421	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000418	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00041	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000405	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00038	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000378	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000374	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000364	CcSEcCtD
Ranolazine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000361	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00036	CcSEcCtD
Ranolazine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000358	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00035	CcSEcCtD
Ranolazine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00034	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000337	CcSEcCtD
Ranolazine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000334	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000333	CcSEcCtD
Ranolazine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000332	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000314	CcSEcCtD
